BioXcel Therapeutics Company
BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.
Founded Date:
2017-01-01
Last Funding Type:
Post-IPO Debt
Headquarters:
New Haven, Connecticut, United States
Investors Number:
2
Technology:
['BioTech & HealthTech']
Employee Number:
101-250
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-04-19
Funding Status:
IPO
Total Funding:
140000000